higher LDL cholesterol (13.7 vs. 12.8 mg/dL, p=0.07). By contrast, there were no differences between the two groups as regards duration of HIV infection, time of exposure to ARVs, (whether considered as a whole or by class), us-CRP, or IL-6. Of the 45 patients with an abnormal CACS, 41 (91.1%) had FRS <20% and would not have been eligible for cardiovascular prevention treatment. These 41 patients represented 22.9% of all patients with FRS <20. None of the 5 patients with CACS > 300 had been identified as high cardiovascular risk patients by FRS.
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"Litigious" exercise training: contribution of myocardial scintigraphy Nadia Diab [Orateur] (1), Rachid Merghit (1), Amira Khelifi (1), Fatiha Menad (2), Sami Nacer Khodja (2), Ali Chalal (2), Hassene Boulaame (1), Ilies Bouaguel (1), Aziz Zenhati (2), El Mehdi Haffaf (2), Naima Adjeroud (1) (1) Hôpital Central de l 'Armée, Cardiologie, Alger, Hôpital Central de l'Armée, Médecine Nucléaire, Alger, Algérie Introduction: In front of an important request for examination of myocardal scintigraphy following a test of "litigious" effort, we are propose to complete this work futurology with an aim of answering the question suggested in title, in referent with the results of the myocardial tomoscintigraphy. Materials and methods: Between January 2008 and May 2010, we investigate 186 consecutive patients presenting of the coronary risk factors addressed for myocardal tomoscintigraphy in front of a test of litigious effort on the electric level carried out within the framework of a search for quiet ischemia. Within the service of nuclear medicine all the patients profited from a test of effort according to the protocol of Bruce, followed by an examination tomoscintigraphy with the MIBI. In the event of a disorder perfusionnel with the myocardic scintiscanning, the patient is taken again for an examination of rest.
Results: There are 105 women and 81 men whose Middle Age is respectively of 57,4 ± 9,3 years and 59,6 ± 8,2 years. The patients are diabetics in 66% of the cases, 78% are women, hypertensive in 53%. The other risk factors are also found with variable proportions. The tests of effort carried out were all maximum. Four 92% of the tests of effort are negative clinically and "wrongfully positive" electrically. The TSM of these patients is normal in 100% of the cases. In 8% of the cases, the test of effort is positive electrically, the TSM is normal not detecting any disorder perfusionnel in 73% of the cases, for the 4 other patients it objectifies disorders perfusionnels; the coronarography of these patients is pathological but without significant lesions except for a patient. This last had in fact finished its test of effort by a nonconstant ventricular tachycardia suggesting a severe ischaemia confirmed with the coronarography. Purpose: the aims of this study were to evaluate the novel biomarker copeptin in combination with troponin I (cTnI), in patients with chest pain presenting to the emergency department (ED), and to determine whether copeptin may allow for a rapid rule out of acute myocardial infarction (AMI). Previous data showed that combined measurement of copeptin and troponin T(cTnT) improved diagnostic performance for rapid rule out of AMI.
Conclusion
Methods: in 97 patients presenting to the ED with suspicion of AMI, we performed at admission, a conventional cTnI assay and a novel copeptin assay.
Results: of 97 patients, 44 (45.4%) had the final diagnosis of AMI, 11(11.3%) of unstable angina and in 42 (43.3%) an acute coronary syndrome (ACS) could be excluded. Patients with AMI, had copeptin levels higher than patients with non ACS (20.12 vs 8.97pmol/l p<0.001). At admission, the aera under curve (AUC) of the receiver-operating characteristic (ROC) curve for the association cTnI / copeptin was not higher than AUC of cTnI (respectively 0.93 vs 0.89; p=0.177). In 60 patients with negative cTnI (< 0.044 μg/L), copeptin (< 14 pmol/L) may allow to rule out AMI with sensitivity of 91.0% and negative predictive value (NPV) of 97.4%.
Conclusions:
conversely to what has been demonstrated for cTnT, no significant difference in AUC was found when Copeptin/cTnI was compared to cTnI alone. This can be explained by the limited set of patients and the relative good result of cTnI AUC. Only combined use of copeptin in negative cTnI patients might help in ruling out AMI because of its good NPV and hence improve triage of patients presenting with chest pain in ED. Purpose: The aim of this work is to study the specific epidemiological, clinical, angiographic and evolving myocardial infarction (MI) of the young subject.
Materials and methods:
It is a descriptive retrospective study ruled in the two services of cardiology of the UHC Mohammed VI de Marrakech from January 2005 to October 2009. We included the patients admitted for MI and paired them in two groups: group1 composed of young patients under 45 years for men and 55 years for women, and group 2 of old patients beyond these age limits. Patients in both groups were investigated focusing in epidemiological analysis of cardiovascular risk factors, an ECG, a biological assessment and a Doppler ultrasound cardiac examination (TTE). The coronarography wasn't realized in all cases.
Hospitalization was the reason for ACS without ST segment elevation in 54.3% in the D group versus 43.8% in the ND group (p=0.03) and for ACS with persistent ST segment elevation in 45.6% in the D group versus 56,1% in the ND group (p=0,02).
Coronary angiography showed: Table I   Table I 
-results of coronary angiography
The syntax score calculated in the D was above 33 in 38.5% versus 11.4% in the ND, treatment was similar in both groups, 209 patients underwent myocardial revascularization, and its method (thrombolysis or coronary angioplasty or coronary artery bypass graft) did not differ by group. Neither hospital mortality nor other complications differed between the two groups.
Conclusion. The ACS in diabetics occurs at a younger age with a male predominance, coronary lesions are more extensive, more severe, often multivessel and distal.
Correct management of ACS and close collaboration between cardiologists and endocrinologists should improve prognosis for patients with diabetes. Introduction: the treatment of ST segment elevation myocardial infarction is to restore permeability of the responsible coronary artery; the goal of our work is to illustrate the benefit of primary angioplasty as an alternative to thrombolysis.
Materials and methods:
This is a retrospective study concerning 75 patients admitted for ST segment elevation myocardial infarction, between January 2008 and February 2010, divided into 2 groups: group [1] n=30, treated by primary angioplasty, compared to the group [2] n=45 thrombolysed.
Results: the average age of our patients is 56.6 ± 6.7 years (group 1) and 55.4 ± 5.9 years (group 2), male is predominant in the 2 groups, most of patients had more than 2 cardiovascular risk factors in the 2 groups.
The time between chest pain and admission to the emergency department is 231min in group 1 versus 247min in group 2, and the period of reperfusion is 281 min in group 1 (door to baloon) versus 277min (onset of chest pain to thrombolysis). In group 1, in addition to medical treatment and primary angioplasty, 3.3% had undergone coronary artery bypass grafting, in group 2, after thrombolysis, 24% benefited from angioplasty, 20% had CABG and 56% was treated medically.
Primary angioplasty has been marked by a primary success, the outcome was good in 83%, stent thrombosis occurred only in 2 cases.
In the second group, the outcome was favourable in only 46%, we deployed a single death due to cardiogenic shock and complications like left ventricular dysfunction in 13%, angina in 13% and arrhythmia in 3%.
Conclusion: the choice of basic therapy in STEMI is mainly based not only on accessibility to the angiography room but on angioplasty reperfusion (door to balloon), as well, when it is available, the angioplasty is highly recommended.
Group 1 N=30

Group 2 N=30
Value of P 
